Showing results (301-310 of 757) with videos related to

Sort By:
Pageof 76
Journal of Inherited Metabolic Disease|October 12, 2012
Cross-sectional baseline analysis of electrocardiography in a large cohort of patients with untreated Fabry diseaseMarkus Niemann, Tanja Hartmann, Mehdi Namdar, et al.
European Heart Journal Open|April 20, 2026
Intraepidermal nerve fiber density as a predictor of cardiac events in Fabry diseaseKolja Lau, Dan Liu, Victoria Sokalski, et al.
The Journal of Clinical Endocrinology and Metabolism|June 3, 2020
Cardiovascular Benefit of Empagliflozin Across the Spectrum of Cardiovascular Risk Factor Control in the EMPA-REG OUTCOME TrialSilvio E Inzucchi, Kamlesh Khunti, David H Fitchett, et al.
Kidney International|December 11, 2002
Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?Martin Zeier, Vedat Schwenger, Reinhold Deppisch, et al.
Nephron. Clinical Practice|November 8, 2014
Longitudinal assessments of erythropoietin-stimulating agent responsiveness and the association with specific clinical outcomes in dialysis patientsAndreas Schneider, Lena Gutjahr-Lengsfeld, Eberhard Ritz, et al.
The American Journal of Cardiology|May 9, 2006
Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathyMeinrad Beer, Frank Weidemann, Frank Breunig, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|May 28, 2013
Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiencyBoris Betz, Kerstin Möller-Ehrlich, Tobias Kress, et al.
Molecular Genetics and Metabolism|January 29, 2023
Patient reported quality of life and medication adherence in Fabry disease patients treated with migalastat: A prospective, multicenter studyJonas Müntze, Kolja Lau, Markus Cybulla, et al.
MMW Fortschritte Der Medizin|April 4, 2024
[InspeCKD - Analysis of the use of diagnostics in patients at high risk for chronic kidney disease in German general practitioner (GP) practices]Christoph Wanner, Elke Schaeffner, Thomas Frese, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 10, 2019
Choice of endpoint in kidney outcome trials: considerations from the EMPA-REG OUTCOME® trialVlado Perkovic, Audrey Koitka-Weber, Mark E Cooper, et al.
Pageof 76